SMPH Funding Opportunities

SMPH Office of Research Administration and Proposal Development (medRAMP)

medRAMP, located in the Dean’s Office of Basic Research, provides information about SMPH funding opportunities described below in addition to a wealth of other funding opportunities both within SMPH and UW-Madison, as well as links to many federal and non-federal funding opportunities for all career levels. Please visit the medRAMP website for more information.

Wisconsin Partnership Program

The Wisconsin Partnership Program has invested $71 million into 98 different faculty research grants since 2004. Those grants have targeted a multitude of issues affecting Wisconsinites, including cancer, infectious disease, obesity, diabetes, children’s health and more.

The Partnership Program currently administers two faculty grant programs.

Collaborative Health Sciences Program

The Collaborative Health Sciences Program provides up to $600,000 over three years to support novel ideas and new approaches to interdisciplinary research or education benefiting Wisconsin’s residents. Collaborative teams are made up of a principal investigator, co-principal investigator(s), and other collaborators. The principal investigator must be a professor, associate professor, senior scientist or distinguished scientist at the UW School of Medicine and Public Health.

New Investigator Program

The New Investigator Program provides up to $100,000 over two years to support early-career faculty in initiating innovative research and/or educational approaches that address Wisconsin’s health issues. The program funds innovative proposals from new faculty that may be leveraged for external funding. Principal investigators must be assistant professors at the UW School of Medicine and Public Health.

medRAMP (SMPH Office of Research Administration and Proposal Development Services)

medRAMP, located in the Dean’s Office of Basic Research, provides information about SMPH funding opportunities

Damon-Runyan Physician-Scientist Training Award

Physician-scientists who are both clinically trained and expert researchers are essential to the successful translation of scientific discovery into more effective patient therapies. They have the unique capacity to blend their insights from treating patients and working in the laboratory in a way that enables and accelerates medical advances. However, the pipeline of physician-scientists is dwindling. The decline in this vital cadre of cancer researchers is occurring at a time when cancer research holds the greatest promise of improving survival and quality of life among cancer patients. A growing shortage of physician-scientists means that major laboratory research discoveries will progress to patient application ever more slowly. If the shortage continues unabated, some may not reach patient application at all, thus presenting a crisis in cancer research.


(Please note: Complete applications and USB flash drives must be received by 3pm on the deadline, not simply postmarked by the deadline.)

  • Application deadline: December 1, 20xx
  • Review panel meeting: Mid-February, 20xx
  • Finalists interview: Spring, 20xx
  • Funding begins: July 1, 20xx

More information is available from the Damon Runyon Cancer Research Foundation.

The DANA Foundation

Science and health grants support research in neuroscience and immunology and their interrelationship in human health and disease.

David Mahoney Neuroimaging Program

Each U.S. medical school dean, and the presidents of the few selected biomedical research institutions that have been invited by letter, may nominate one applicant. Please check the website and let your SMPH Dean’s Office ( know if you are interested in applying as there may need to be an internal competition.

  • Research on imaging innovations that help reveal how the human brain functions normally, how disorders and injuries alter these functions, and how various therapies affect those conditions. Funded research also can focus on immune cell interactions with brain cells.
  • Clinical Neuroscience Research: Support for “first in humans” studies of patients with devastating brain diseases for which there currently is no effective treatment. Funded researchers set up controlled clinical studies in patients with a specific brain disease, based on promising animal studies suggesting that a specific therapy either treats the condition or prevents it from getting worse.

View more information

Doris Duke Charitable Foundation - Medical Research

The Doris Duke Charitable Foundation will only award grants to a 501.c.3 entity so the proposal will need to go through the UW Foundation. Once the award is issued, it will be brought over to the UW and administered through Fund 133.

Doris Duke no longer requires institutional nomination. Gillian Fink, ( at the UW Foundation is familiar with Doris Duke and has been helpful in submitting past proposals to them.

More information is available from the Doris Duke Charitable Foundation.

The Hartwell Foundation

The Hartwell Foundation Individual Biomedical Research Award provides financial support to stimulate discovery in early-stage biomedical research that will benefit children. The Hartwell Foundation requires each selected research institution to hold an internal open competition annually to identify up to four nominees, based upon application requirements set forth by the Foundation.




  • Proposals must describe early-stage, innovative and cutting-edge biomedical research that will benefit children.
  • Proposals should be from appropriate areas of basic and applied life sciences, principally limited to medicine and biomedical engineering.
  • The research proposed may not have had significant funding from outside sources.
  • Proposals should be based on sound science and should “make a difference.”
  • Awards are $100,000/year for three years.
  • All recipients must be U.S. citizens or permanent residents who hold a full-time appointment and be able to serve as PI.

Lily's Fund for Epilepsy Research

Lily’s Fund provides support for epilepsy-related research through two funding mechanisms that are offered in alternating years.

Lily’s Fund Fellowships

The Lily’s Fund Fellowship will provide financial support for research training in epilepsy-related research. The successful candidate will be mentored by a UW-Madison faculty member to develop critical skills in research, advance their understanding of epilepsy and related scientific issues, and commence a career in epilepsy-related research.

The Lily’s Fund Fellowship provides up to 2 years of pre- or post-doctoral funding at one-half of current NIH NRSA stipend levels, plus fringe benefits. The applicant’s mentor must identify matching funds to fund the Fellowship fully. To be eligible for a Lily’s Fund Fellowship, pre-doctoral applicants must have achieved dissertator status, and post-doctoral applicants must have received their M.D. or Ph.D. degrees. All applicants must desire experience in epilepsy related research. Clinical fellows are eligible, but support will be limited to the research year, and matching funds are still required. Mentors are encouraged to recruit nationally and internationally for this fellowship opportunity.

Grace Grants

Grace Grants applications should propose innovative research that, if successful, will enrich our understanding of epilepsy, advance new epilepsy treatments, identify new diagnostic tools or otherwise improve quality of life for those who live with epilepsy. A priority will be given to new projects that spark new thinking and open new avenues of inquiry into the mechanisms of epilepsy. The Lily’s Fund Grace Grants provide up to $100,000 ($50,000 per year) over two years. Applications may be submitted by any UW-Madison faculty or academic staff member(s) who have the skills, knowledge and resources necessary to carry out meaningful epilepsy-related research.

For more information, please contact Chrissy Pientok at